Key terms

About CMRX

Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded in April 2000 and is headquartered in Durham, NC.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest CMRX news

May 03 3:05pm ET Buy Rating Justified by Chimerix’s Upcoming Catalysts and Strong Financials by TipRanks May 02 6:30am ET Strong Buy Rating for Chimerix on Robust Financials and Promising Drug Pipeline by TipRanks May 01 6:35pm ET Chimerix’s Strong Financials and Promising ONC201 Developments Merit Buy Rating by TipRanks May 01 8:33am ET Chimerix Releases Updated Corporate Presentation for Investors by TipRanks May 01 7:04am ET Chimerix reports Q1 EPS (25c), consensus (22c) by TipRanks Mar 22 11:33am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Mar 21 8:42am ET Chimerix Board Changes: Machado Resigns, Kozin Appointed by TipRanks Mar 21 7:19am ET Chimerix appoints Kozin to board of directors by TipRanks Mar 05 1:31am ET Analysts Offer Insights on Healthcare Companies: Chimerix (CMRX), DENTSPLY SIRONA (XRAY) and Karuna Therapeutics (KRTX) by TipRanks Mar 01 6:30am ET Analysts Are Bullish on Top Healthcare Stocks: Argenx Se (ARGX), Bio-Rad Laboratories (BIO) by TipRanks Feb 29 10:00pm ET Analysts Offer Insights on Healthcare Companies: BioLife Solutions (BLFS) and Chimerix (CMRX) by TipRanks Feb 29 3:10pm ET Analysts’ Top Healthcare Picks: Chimerix (CMRX), MoonLake Immunotherapeutics (MLTX) by TipRanks Feb 29 11:55am ET Buy Rating Affirmed for Chimerix Amid Progress in Dordaviprone’s Phase III Study and Strong Financial Outlook by TipRanks Feb 29 9:24am ET Chimerix files $250M mixed securities shelf by TipRanks Feb 29 8:14am ET Chimerix Unveils New Corporate Presentation for Investors by TipRanks Feb 29 7:04am ET Chimerix reports Q4 EPS (20c), consensus (24c) by TipRanks Feb 15 11:05am ET Biotech Alert: Searches spiking for these stocks today by TipRanks

No recent press releases are available for CMRX

CMRX Financials

1-year income & revenue

Key terms

CMRX Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

CMRX Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Warren Buffett (L), CEO of Berkshire Hathaway, and Vice Chairman Charlie Munger attend the 2019 annual shareholders meeting in Omaha, Nebraska, May 3, 2019.
Johannes Eisele/AFP/Getty Images
Warren Buffett holds first Berkshire Hathaway meeting without Charlie Munger
People walk by the New York Stock Exchange (NYSE) on March 20, 2024 in New York City. The Dow was up slightly in late morning trading as traders analyze the Federal Reserve's latest decision on interest rates.
Spencer Platt/Getty Images
Stocks close higher after softer-than-expected jobs report fuels hopes of an earlier rate cut
People work at a Starbucks in Manhattan on February 02, 2024 in New York City.
Spencer Platt/Getty Images
Restaurants are competing for frugal diners’ dollars
Traders work on the floor of the New York Stock Exchange during afternoon trading on April 09, 2024 in New York City.
Michael M. Santiago/Getty Images/File
Sell in May and go away? Think again